Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

2.100 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,850
Open 2.100
Bid (Size) 2.050 (4)
Ask (Size) 2.110 (10)
Prev. Close 2.100
Today's Range 2.030 - 2.140
52wk Range 0.1800 - 8.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
From Mainz BioMed NV
Via GlobeNewswire
These stocks are moving in today's pre-market session
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill

Performance

YTD
-51.2%
-51.2%
1 Month
-33.3%
-33.3%
3 Month
-63.4%
-63.4%
6 Month
+912.0%
+912.0%
1 Year
+273.1%
+273.1%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
From Mainz BioMed NV
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet
Via Stocktwits
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Expands into Switzerland with labor team w
From Mainz BioMed NV
Via GlobeNewswire
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
From Mainz BioMed NV
Via GlobeNewswire
Which stocks are moving after the closing bell on Friday?
Via Chartmill
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
From Mainz BioMed NV
Via GlobeNewswire
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Via News Direct
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Via Benzinga

Frequently Asked Questions

Is Mainz Biomed N.V. - Ordinary Shares publicly traded?
Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.
What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?
Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?
The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market
What is the current price of Mainz Biomed N.V. - Ordinary Shares?
The current price of Mainz Biomed N.V. - Ordinary Shares is 2.100
When was Mainz Biomed N.V. - Ordinary Shares last traded?
The last trade of Mainz Biomed N.V. - Ordinary Shares was at 05/23/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.